ID

24596

Descrição

Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive

Palavras-chave

Versões (2)
  1. 27/07/2017 27/07/2017 -
  2. 08/08/2017 08/08/2017 -
Transferido a

8 de agosto de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

Inglês

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 Formulários  
Administrative Data
Descrição

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Descrição

subject identifier

Tipo de dados

integer

Alias
UMLS CUI [1]
C2348585
ELIGIBILITY QUESTION
Descrição

ELIGIBILITY QUESTION

Alias
UMLS CUI-1
C0013893
Did the subject meet all the randomisation criteria?
Descrição

randomisation criteria

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0243161
INCLUSION CRITERIA
Descrição

INCLUSION CRITERIA

Alias
UMLS CUI-1
C1512693
Achieves a BDI focal score of ≤ 7 units at Visit 2
Descrição

baseline dysnpnoea index

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1511069
Achieves a composite VAS score of ≥120 (out of 400 maximum) on 4 or more days over the 7 days immediately prior to Visit 2.
Descrição

VAS referring to COPD symptoms

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3536884
UMLS CUI [1,2]
C1737716
Is able to complete a Daily Record Card.
Descrição

ability of daily documentation

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0920316
UMLS CUI [1,2]
C0332173
UMLS CUI [1,3]
C0085732
Is able to demonstrate correct use of DISKUS/ACCUHALER.
Descrição

ability to show the correct inhaler technique

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0419833
EXCLUSION CRITERIA
Descrição

EXCLUSION CRITERIA

Alias
UMLS CUI-1
C0680251
Has less than 4 consecutive days with complete run-in DRC data within the 7 consecutive days prior to Visit 2.
Descrição

incomplete documentation of the daily record card

Tipo de dados

boolean

Alias
UMLS CUI [1]
C3845717
Has (in the opinion of the investigator) a clinically significant abnormal clinical haematology and chemistry or cortisol value at Visit 1.
Descrição

abnormal clinical haematology and chemistry or cortisol level

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1332129
UMLS CUI [2]
C0428396
Has experienced a moderate or severe exacerbation of their COPD during the Run-In period.
Descrição

COPD exacerbation

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0740304
Subjects who have had a change to their COPD medication or taken non-permitted medications, other than "as required" use of VENTOLIN for the management of COPD exacerbations between Visits 1 and 2.
Descrição

change in COPD medication or medication other than the permitted

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0024117
UMLS CUI [1,2]
C0580105
UMLS CUI [2]
C1115771
Voltar ao início da página

Similar models

visit 2 (inclusion/exclusion criteria) salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
subject identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item Group
ELIGIBILITY QUESTION
C0013893 (UMLS CUI-1)
Item
Did the subject meet all the randomisation criteria?
text
C0034656 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
randomisation criteria
Code List
Did the subject meet all the randomisation criteria?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
INCLUSION CRITERIA
C1512693 (UMLS CUI-1)
baseline dysnpnoea index
Item
Achieves a BDI focal score of ≤ 7 units at Visit 2
boolean
C1511069 (UMLS CUI [1])
visual analog scale of COPD symptoms
Item
Achieves a composite VAS score of ≥120 (out of 400 maximum) on 4 or more days over the 7 days immediately prior to Visit 2.
boolean
C3536884 (UMLS CUI [1,1])
C1737716 (UMLS CUI [1,2])
ability of daily documentation
Item
Is able to complete a Daily Record Card.
boolean
C0920316 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
ability to show the correct inhaler technique
Item
Is able to demonstrate correct use of DISKUS/ACCUHALER.
boolean
C0419833 (UMLS CUI [1])
Item Group
EXCLUSION CRITERIA
C0680251 (UMLS CUI-1)
incomplete documentation of the daily record card
Item
Has less than 4 consecutive days with complete run-in DRC data within the 7 consecutive days prior to Visit 2.
boolean
C3845717 (UMLS CUI [1])
abnormal clinical haematology and chemistry or cortisol level
Item
Has (in the opinion of the investigator) a clinically significant abnormal clinical haematology and chemistry or cortisol value at Visit 1.
boolean
C1332129 (UMLS CUI [1])
C0428396 (UMLS CUI [2])
COPD exacerbation
Item
Has experienced a moderate or severe exacerbation of their COPD during the Run-In period.
boolean
C0740304 (UMLS CUI [1])
change in COPD medication or medication other than the permitted
Item
Subjects who have had a change to their COPD medication or taken non-permitted medications, other than "as required" use of VENTOLIN for the management of COPD exacerbations between Visits 1 and 2.
boolean
C0024117 (UMLS CUI [1,1])
C0580105 (UMLS CUI [1,2])
C1115771 (UMLS CUI [2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial